过去一年中添加的文章,按日期排序
Mitochondrial Proteome Defined Molecular Pathological Characteristics of Oncocytic Thyroid Tumors
L Li, L Zhang, W Jiang, Z Gui, Z Wang, H Zhang… - Endocrine …, 2024 - Springer
4 天前 - … follicular thyroid adenoma (FTA), 21 follicular thyroid carcinoma (… TERT promoter
mutations, which were only detected in OCAs. Previous studies did not analyze the mutations …
mutations, which were only detected in OCAs. Previous studies did not analyze the mutations …
Association Between Gross Features and Coexistence of BRAFV600E and TERT Promoter Mutations in Papillary Thyroid Carcinomas: A Combined Analysis …
TNA Nguyen, VPT Nguyen, H Kurohama, Y Akazawa… - Thyroid, 2024 - liebertpub.com
9 天前 - … The genetic duet of BRAF V600E and TERT promoter mutations predicts the poor
curative effect of radioiodine therapy in papillary thyroid cancer. Eur J Nucl Med Mol Imaging …
curative effect of radioiodine therapy in papillary thyroid cancer. Eur J Nucl Med Mol Imaging …
Clinically aggressive Follicular Cell-Derived Thyroid Carcinoma: A Comprehensive Series with Histomolecular Characterization and Discovery of Novel Gene Fusions
Z Alsugair, F Descotes, J Lopez, H Lasolle, FB Chazot… - Human Pathology, 2024 - Elsevier
11 天前 - … thyroid carcinomas were predominant. The molecular analysis revealed a spectrum
… mutations, with prevalent occurrences of BRAF V600E, TERT promoter, and RAS mutations…
… mutations, with prevalent occurrences of BRAF V600E, TERT promoter, and RAS mutations…
다양한갑상선암종에서텔로머레이스역전사효소(TERT) 프로모터돌연변이예측인자로서의TERT 와5-하이드록시메틸사이토신면역조직화학의평가
안형록 - 2024 - oak.ulsan.ac.kr
12 天前 - … predictive biomarker for TERT promoter mutation. Materials … TERT mutant group
and 61 patients in TERT wild group) with thyroid carcinoma and the presence of TERT promoter …
and 61 patients in TERT wild group) with thyroid carcinoma and the presence of TERT promoter …
Molecular prognostication of thyroid tumors: with special focus on TERT
S Hellgren - 2024 - openarchive.ki.se
18 天前 - … In conclusion, ddPCR proved highly effective in detecting TERT promoter mutations
in … to detect TERT promoter mutations in minimally invasive follicular thyroid carcinoma (…
in … to detect TERT promoter mutations in minimally invasive follicular thyroid carcinoma (…
Oncogenic mutations in the TP53 and PI-3 kinase/AKT pathway are independent predictors of survival for advanced thyroid cancer: Analysis from the Molecular …
22 天前 - … characterized several oncogenic mutations, allowing a better understanding of why
certain thyroid cancers behave more aggressively. TERT promoter mutations, for instance, …
certain thyroid cancers behave more aggressively. TERT promoter mutations, for instance, …
[HTML][HTML] Aspetti clinici e analisi molecolare delle neoplasie tiroidee a basso rischio: uno studio retrospettivo monocentrico.
L DI LAZZARO - thesis.unipd.it
24 天前 - … TERT promoter mutation was evaluated in only 29 patients (33,3%): in 1 case (3,5%)
a pTERT mutation … Conclusions: Based on this study, low-risk thyroid cancers all seem to …
a pTERT mutation … Conclusions: Based on this study, low-risk thyroid cancers all seem to …
[HTML][HTML] Small Multi-Gene DNA Panel Can Aid in Reducing the Surgical Resection Rate and Predicting the Malignancy Risk of Thyroid Nodules
MY Oh, HM Choi, J Jang, H Son… - Endocrinology and …, 2024 - synapse.koreamed.org
26 天前 - … with high-risk cancers (TERT promoter, PIK3CA, and TP53). … all known mutations
associated with thyroid cancers, as … increase active surveillance of thyroid cancer with low risk …
associated with thyroid cancers, as … increase active surveillance of thyroid cancer with low risk …
[HTML][HTML] Clinical and Histopathological Features of Thyroid Cancer with TERT Promoter Molecular Alterations in Isolation Versus with Concurrent Molecular …
E Steinberg, O Dimitstein, GB Morand, VI Forest… - Cancers, 2024 - mdpi.com
29 天前 - … Methods: This study examined patients with thyroid cancer treated at two tertiary
care hospitals from 2017 to 2024. We compared tumor behavior in patients with TERTp …
care hospitals from 2017 to 2024. We compared tumor behavior in patients with TERTp …
6847 Poorly Differentiated Thyroid Cancer: A Rare Entity
S Fatima, S Ward, A Champion - Journal of the Endocrine …, 2024 - academic.oup.com
35 天前 - … in 25–35%, BRAF mutation in 15–27%, TERT promoter mutation in 40% and mutant
TP53 in 16–28% of PDTCs. TERT promoter gene and TP53 mutation usually indicate an …
TP53 in 16–28% of PDTCs. TERT promoter gene and TP53 mutation usually indicate an …